237 related articles for article (PubMed ID: 27564413)
21. Computed tomography structural lung changes in discordant airflow limitation.
Mohamed Hoesein FA; de Jong PA; Lammers JW; Mali WP; Schmidt M; de Koning HJ; van der Aalst C; Oudkerk M; Vliegenthart R; van Ginneken B; van Rikxoort EM; Zanen P
PLoS One; 2013; 8(6):e65177. PubMed ID: 23785411
[TBL] [Abstract][Full Text] [Related]
22. How Common Is Airflow Limitation in Patients With Emphysema on CT Scan of the Chest?
Lutchmedial SM; Creed WG; Moore AJ; Walsh RR; Gentchos GE; Kaminsky DA
Chest; 2015 Jul; 148(1):176-184. PubMed ID: 25539080
[TBL] [Abstract][Full Text] [Related]
23. The objective evaluation of obstructive pulmonary diseases with spirometry.
Ozkaya S; Dirican A; Tuna T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
[TBL] [Abstract][Full Text] [Related]
24. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
Martinez CH; Murray S; Barr RG; Bleecker E; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper D; Criner GJ; Curtis JL; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Krishnan JA; Lazarus SC; Leidy NK; O'Neal W; Martinez FJ; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Han MK;
Ann Am Thorac Soc; 2017 May; 14(5):636-642. PubMed ID: 28459622
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary Artery Abnormalities in Ex-smokers with and without Airflow Obstruction.
Lindenmaier TJ; Kirby M; Paulin G; Mielniczuk L; Cunningham IA; Mura M; Licskai C; Parraga G
COPD; 2016; 13(2):224-34. PubMed ID: 26606693
[TBL] [Abstract][Full Text] [Related]
26. Clinical and Radiologic Disease in Smokers With Normal Spirometry.
Regan EA; Lynch DA; Curran-Everett D; Curtis JL; Austin JH; Grenier PA; Kauczor HU; Bailey WC; DeMeo DL; Casaburi RH; Friedman P; Van Beek EJ; Hokanson JE; Bowler RP; Beaty TH; Washko GR; Han MK; Kim V; Kim SS; Yagihashi K; Washington L; McEvoy CE; Tanner C; Mannino DM; Make BJ; Silverman EK; Crapo JD;
JAMA Intern Med; 2015 Sep; 175(9):1539-49. PubMed ID: 26098755
[TBL] [Abstract][Full Text] [Related]
27. Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study.
Buhr RG; Barjaktarevic IZ; Quibrera PM; Bateman LA; Bleecker ER; Couper DJ; Curtis JL; Dolezal BA; Han MK; Hansel NN; Krishnan JA; Martinez FJ; McKleroy W; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Kanner RE; Cooper CB;
Am J Respir Crit Care Med; 2022 Sep; 206(5):554-562. PubMed ID: 35549640
[No Abstract] [Full Text] [Related]
28. Subtyping preserved ratio impaired spirometry (PRISm) by using quantitative HRCT imaging characteristics.
Lu J; Ge H; Qi L; Zhang S; Yang Y; Huang X; Li M
Respir Res; 2022 Nov; 23(1):309. PubMed ID: 36369019
[TBL] [Abstract][Full Text] [Related]
29. A New Bronchodilator Response Grading Strategy Identifies Distinct Patient Populations.
Hansen JE; Dilektasli AG; Porszasz J; Stringer WW; Pak Y; Rossiter HB; Casaburi R
Ann Am Thorac Soc; 2019 Dec; 16(12):1504-1517. PubMed ID: 31404502
[No Abstract] [Full Text] [Related]
30. Significance of FEV
Yee N; Markovic D; Buhr RG; Fortis S; Arjomandi M; Couper D; Anderson WH; Paine R; Woodruff PG; Han MK; Martinez FJ; Barr RG; Wells JM; Ortega VE; Hoffman EA; Kim V; Drummond MB; Bowler RP; Curtis JL; Cooper CB; Tashkin DP; Barjaktarevic IZ
Chest; 2022 Apr; 161(4):949-959. PubMed ID: 34767825
[TBL] [Abstract][Full Text] [Related]
31. Occupational exposure to vapor, gas, dust, or fumes and chronic airflow limitation, COPD, and emphysema: the Swedish CArdioPulmonary BioImage Study (SCAPIS pilot).
Torén K; Vikgren J; Olin AC; Rosengren A; Bergström G; Brandberg J
Int J Chron Obstruct Pulmon Dis; 2017; 12():3407-3413. PubMed ID: 29238185
[TBL] [Abstract][Full Text] [Related]
32. Using Novel Computed Tomography Analysis to Describe the Contribution and Distribution of Emphysema and Small Airways Disease in Chronic Obstructive Pulmonary Disease.
Ostridge K; Gove K; Paas KHW; Burke H; Freeman A; Harden S; Kirby M; Peterson S; Sieren J; McCrae C; Vaarala O; Staples KJ; Wilkinson TMA
Ann Am Thorac Soc; 2019 Aug; 16(8):990-997. PubMed ID: 30892055
[No Abstract] [Full Text] [Related]
33. Is the Slow Vital Capacity Clinically Useful to Uncover Airflow Limitation in Subjects With Preserved FEV
Saint-Pierre M; Ladha J; Berton DC; Reimao G; Castelli G; Marillier M; Bernard AC; O'Donnell DE; Neder JA
Chest; 2019 Sep; 156(3):497-506. PubMed ID: 30768928
[TBL] [Abstract][Full Text] [Related]
34. Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity.
Harvey BG; Strulovici-Barel Y; Kaner RJ; Sanders A; Vincent TL; Mezey JG; Crystal RG
Eur Respir J; 2015 Dec; 46(6):1589-1597. PubMed ID: 26541521
[TBL] [Abstract][Full Text] [Related]
35. Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.
Gelb AF; Yamamoto A; Verbeken EK; Schein MJ; Moridzadeh R; Tran D; Fraser C; Barbers R; Elatre W; Koss MN; Glassy EF; Nadel JA
Chest; 2018 Mar; 153(3):618-629. PubMed ID: 29197547
[TBL] [Abstract][Full Text] [Related]
36. Percent emphysema, airflow obstruction, and impaired left ventricular filling.
Barr RG; Bluemke DA; Ahmed FS; Carr JJ; Enright PL; Hoffman EA; Jiang R; Kawut SM; Kronmal RA; Lima JA; Shahar E; Smith LJ; Watson KE
N Engl J Med; 2010 Jan; 362(3):217-27. PubMed ID: 20089972
[TBL] [Abstract][Full Text] [Related]
37. Parametric response mapping monitors temporal changes on lung CT scans in the subpopulations and intermediate outcome measures in COPD Study (SPIROMICS).
Boes JL; Hoff BA; Bule M; Johnson TD; Rehemtulla A; Chamberlain R; Hoffman EA; Kazerooni EA; Martinez FJ; Han MK; Ross BD; Galbán CJ
Acad Radiol; 2015 Feb; 22(2):186-94. PubMed ID: 25442794
[TBL] [Abstract][Full Text] [Related]
38. Parametric Response Mapping as an Imaging Biomarker in Lung Transplant Recipients.
Belloli EA; Degtiar I; Wang X; Yanik GA; Stuckey LJ; Verleden SE; Kazerooni EA; Ross BD; Murray S; Galbán CJ; Lama VN
Am J Respir Crit Care Med; 2017 Apr; 195(7):942-952. PubMed ID: 27779421
[TBL] [Abstract][Full Text] [Related]
39. Maximal mid-expiratory flow detects early lung disease in α
Stockley JA; Ismail AM; Hughes SM; Edgar R; Stockley RA; Sapey E
Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28356373
[TBL] [Abstract][Full Text] [Related]
40. Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years.
Bhatt SP; Kim YI; Harrington KF; Hokanson JE; Lutz SM; Cho MH; DeMeo DL; Wells JM; Make BJ; Rennard SI; Washko GR; Foreman MG; Tashkin DP; Wise RA; Dransfield MT; Bailey WC;
Thorax; 2018 May; 73(5):414-421. PubMed ID: 29326298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
